| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |